News

2022

company

year

domain

Flagship Pioneering Launches Apriori Bio to Provide Variant-Proof Protection from the Greatest Viral Threats

Apriori Bio 07.11.2022

Flagship Pioneering Unveils ProFound™ Therapeutics to Illuminate an Expanded Universe of Human Proteins with the Potential to Enable a Multitude of New Medicines

ProFound™ Therapeutics 05.26.2022

Evelo Biosciences Announces $79.2 Million Registered Direct Offering of Common Stock

Evelo Biosciences 05.25.2022

Evelo Biosciences Announces First Quarter 2022 Financial Results and Business Highlights

Evelo Biosciences 05.12.2022

Evelo Biosciences Appoints John Maraganore, Ph.D. and Tassos Gianakakos as Strategic Advisors

Evelo Biosciences 04.21.2022

Flagship Pioneering Bolsters Executive Team with Appointment of Michelle C. Werner as CEO-Partner and CEO of Alltrna

04.11.2022

Evelo Biosciences Announces Appointments of Jose-Carlos Gutiérrez-Ramos and Tonya Williams to Board of Directors

Evelo Biosciences 04.06.2022

Flagship Pioneering Unveils Vesalius Therapeutics to Revolutionize the Treatment of the Diseases that Drive Ninety Percent of Human Illness

03.02.2022

Flagship Pioneering Announces Christopher Austin, M.D., Honored as a Lifetime AAAS Fellow

02.01.2022

Flagship Pioneering Announces Appointment of Tom DiLenge as Senior Partner, Global Public Policy, Regulatory & Governmental Strategy

01.25.2022

Loading